SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology & Drugs -- Ignore unavailable to you. Want to Upgrade?


To: SusieQ1065 who wrote (119)7/18/2002 11:20:53 AM
From: 2MAR$  Read Replies (2) | Respond to of 232
 
ICOS ICOS sells off, despite Lilly reaffirming Cialis launch (did bounce off $14 --->15.20 -1.59)
Stock is getting slammed (-10.6%) on news of continuing manufacturing problems at LLY; however, Dow Jones reports that LLY says manufacturing issues will not hurt the co's impotence drug Cialis (jointly-developed with ICOS), which is expected to launch in 2H03.

certain someone brings out the best in me too ;-)